BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 6103653)

  • 61. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
    Mita T; Hanada S; Nishino N; Kuno T; Nakai H; Yamadori T; Mizoi Y; Tanaka C
    Biol Psychiatry; 1986 Dec; 21(14):1407-14. PubMed ID: 2947636
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 63. Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions.
    Murrin LC; Gale K; Kuhar MJ
    Eur J Pharmacol; 1979 Dec; 60(2-3):229-35. PubMed ID: 43260
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia [proceedings].
    Bird ED; Crow TJ; Iversen LL; Longden A; Mackay AV; Riley GJ; Spokes EG
    J Physiol; 1979 Aug; 293():36P-37P. PubMed ID: 501607
    [No Abstract]   [Full Text] [Related]  

  • 66. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C; Ogren SO; Haglund L; Angeby T
    Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
    Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
    Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine.
    Brain Res; ; . PubMed ID: 3719352
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.